Volume : 08, Issue : 11, November – 2021
Title:
14.TO DETERMINE THE HIGH RISK OF EARLY COMPLICATION RATE AMONG NORMAL RENAL FUNCTION PATIENTS VERSUS IMPAIRED RENAL FUNCTION PATIENTS IN POSTOPERATIVE AUGMENTATION CYSTOPLASTY
Authors :
Dania Masood, Abbas Jafri, Sunil Kumar, Mazahir, Usman Qamar, Murli Lal
Abstract :
OBJECTIVE: “To determine the high risk of early complication rate among normal renal function patients versus impaired renal function patients in postoperative augmentation cystoplasty”
MATERIAL AND METHODS: We retrospectively analyzed a total of 40 patients; 20 patients are in Group A (normal renal functioning) 20 patients are in Group B (impaired renal functioning) in which 26 male and 14 females who underwent augmentation cystoplasty and were registered during last 5 years starting from January 2015 till December 2019.
RESULTS: The mean ages of these patients were 31.73 ± 10.73in the range of 1856 years and there were 65% males and 35% females in these groups. In early postoperative duration the differences of early complications in both groups up to three months of follow-up were observed. Out of 20 patients in each groups 14 (70%) were presented with fever in group A and 17(85%) were in group Band (P=0.451), whereas Hematuria occurs in 2 (10%) patients of group A and 3 (15%) patients of group B and (P=0.999), the symptoms of Post operative ileus were seen in 13 (65%) patients in group A and 18 (90%) in group B and (P=0.127), while the occurrence of Surgical site infection was observed in 9 (45%) patient in group A and 13 (65%) patients in group Band (P=0.202), and Urinary leakage was seen in 3 (15%) patients in group A and in 5 (25%) were in group B (25%) and (P=0.695), however Deep venous thrombus/pulmonary edema in 1 (5%) patients in group A and 2 (10%) in group Band (P=1.000), whereas Fecal leakage and Ruptured augmented bladder has not occur in both groups and these groups are constant.
CONCLUSION: In our study the higher risk of early complications rate was seen in impaired renal function patients as compared to normal renal function patients within 3 months follow-up in SIUT. We concluded that patients with increased baseline creatinine levels after surgery are prone to develop early complications in postoperative duration.
KEYWORDS: Augmentation cystoplasty, ileocystoplasty, bladder augmentation, small capacity bladder, enter cystoplasty.
Cite This Article:
Please cite this article in press Dania Masood et al, To Determine The High Risk Of Early Complication Rate Among Normal Renal Function Patients Versus Impaired Renal Function Patients In Postoperative Augmentation Cystoplasty, Indo Am. J. P. Sci, 2021; 08(11).
Number of Downloads : 10
References:
1. Operative Urology (surgical skills) by Robert J. Krane, Mike B. Siroky, John M Fitzpatrick
2. Quek ML, Ginsberg DA (2003) Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol 169(1):195–198. https://doi.org/10.1097/01.ju.00000 39782 .13395 .0a
3. Mikulicz J. Zur Operation der angeborenen Blasenspalte. Zentralbl Chir. 1899;26:641.
4. Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU Int. 2012;109:1280–1293.
5. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent selfcatheterization in the treatment of urinary tract disease. Trans Am Assoc Genitourin Surg. 1971;63:92–96.
6. Operative Urology (surgical skills) by Robert J. Krane, Mike B. Siroky, John Fitzpatrick
7. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0020323
8. Welk B, Herschorn S, Law C, Nam R. Population based assessment of enterocystoplasty complications in adults. J Urol. 2012;188:464–469.
[PubMed] [Google Scholar]
9. Shreck E, Gioia K, Lucioni A. Indications for augmentation cystoplasty in the era of onabotulinumtoxinA. Curr Urol Rep. 2016;17:27. [PubMed]
[Google Scholar]
10. Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU Int. 2012;109:1280–1293. [PubMed]
[Google Scholar]
11. https://www.researchgate.net/publication/234061226_Complications_follow ing_augmentation_cystoplasty_prevention_and_managent
12. Reyblat P, Ginsberg DA. Augmentation cystoplasty: what are the indications? Curr Urol Rep. 2008;9:452–458. [PubMed] [Google Scholar]
13. Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJU Int. 2012; 109(9):1280-1293.
doi:10.1111/j.1464-410X.2011.10650.x
14. Bhatnagar V , Dave S , Agarwala S ,Mitra DK .
Augmentationcolocystoplasty in bladder exstrophy .Pediatr SurgInt 2002 ;
18 : 43 – 9
15. Surer I , Ferrer FA , Baker LA , Gearhart JP . Continent urinary diversion and theexstrophy-epispadias complex .J Urol2003 ; 169 : 1102 – 5
16. Mehmood S, Seyam R, Firdous S, Altaweel WM. Factors Predicting Renal
Function Outcome after Augmentation Cystoplasty. Int J Nephrol. 2017;
2017:3929352. doi:10.1155/2017/3929352
17. Çetinel B, Kocjancic E, Demirdağ Ç. Augmentation cystoplasty in neurogenic bladder. Investig Clin Urol. 2016; 57(5):316-323. doi:10.4111/icu.2016.57.5.316
18. Mehmood S, Seyam R, Firdous S, Altaweel WM. Factors Predicting Renal Function Outcome after Augmentation Cystoplasty. Int J Nephrol. 2017;
2017:3929352. doi:10.1155/2017/3929352
19. Kluger MJ (2015). Fever: Its Biology, Evolution, and Function. Princeton University Press. p. 57. ISBN 978-1400869831.
20. Augmentation cystoplasty in neurogenic bladder. Bulent cetinel, department of urology,Urol 2016;57:316-323.
21. Shekarriz B, Upadhyay J, Demirbilek S et al.: Surgicalcomplications of bladder augmentation: comparison betweenvarious enterocystoplasties in patients. Urology 2000, 55:123–12.
22. Flood HD, Malhotra SJ, O’Connell HE et al.: Long-term resultsand complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodynamics 1995, 14: 297–309.